What Does Evelo Biosciences Do?

Total employees22
HeadquartersCambridge
Founded2015

Evelo Biosciences was a clinical-stage biotechnology company focused on developing orally-delivered, gut-restricted medicines, specifically monoclonal microbials, to act on the small intestinal axis (SINTAX) for the treatment of inflammatory diseases. The company aimed to discover and develop therapies that could address a broad range of immune-related conditions. Evelo Biosciences was founded by Flagship Pioneering. In October 2023, Evelo Biosciences filed for Chapter 7 bankruptcy and subsequently ceased all operations.

Where Is Evelo Biosciences's Headquarters?

HQ Function

The Cambridge headquarters served as the central location for Evelo's research and development activities, clinical operations, and corporate administration before the company ceased operations.

Notable Features:

The facility likely included advanced laboratory spaces for microbial candidate development and analysis, along with office areas designed for a biotech research environment. Its location in Cambridge offered proximity to leading academic institutions and other biotech companies.

Work Culture:

As a clinical-stage biotechnology company, the work culture at Evelo Biosciences likely emphasized scientific innovation, collaboration, a fast-paced environment driven by research milestones, and a strong focus on translating scientific discoveries into potential therapies. This culture ceased with the company's dissolution.

HQ Significance:

The Cambridge headquarters was significant due to its strategic location within a leading global biotech ecosystem, providing access to talent, research collaborations, and venture capital. This environment was crucial for its R&D efforts.

Values Reflected in HQ: The headquarters' location and setup would have reflected values of cutting-edge science, innovation, and the pursuit of novel therapeutic approaches, characteristic of companies spun out of venture creation firms like Flagship Pioneering.

Location:

Prior to ceasing operations, Evelo Biosciences was primarily based in the United States. Its global presence was mainly through its clinical trial activities, which may have involved sites and collaborations in various countries to test its investigational therapies. The company did not have significant physical office locations outside of its Cambridge, MA headquarters.

Street Address:

620 Memorial Dr, Suite 200W

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Evelo Biosciences Operate Around the World?

No additional office locations available.

Buying Intent Signals for Evelo Biosciences

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Evelo Biosciences? Meet the Executive Team

As of April 2025, Evelo Biosciences' leadership includes:

Balkrishan (Simba) Gill, Ph.D. - Former President and Chief Executive Officer
Luca Scavo - Former Chief Financial Officer and Chief Business Officer (until Oct 2023)
Mark Bodmer, Ph.D. - Former Chief Scientific Officer
Duncan McHale, M.B.B.S., Ph.D. - Former Chief Medical Officer
David Epstein - Former Executive Chairman

Who's Investing in Evelo Biosciences?

Evelo Biosciences has been backed by several prominent investors over the years, including:

Flagship Pioneering
GV (Google Ventures)
Celgene (acquired by Bristol Myers Squibb)
Mayo Clinic
Alexandria Venture Investments
Fidelity Management & Research Company
T. Rowe Price
BVF Partners L.P.

What Leadership Changes Has Evelo Biosciences Seen Recently?

Hire1
Exits2

In the year leading up to its bankruptcy, Evelo Biosciences experienced key executive changes, notably in its CFO position. The Chapter 7 filing in October 2023 ultimately resulted in the departure of all remaining executives as the company ceased operations.

Departures

Marella Thorell, Marella Thorell resigned as Chief Financial Officer.
All Executives, All executive staff departed due to company dissolution following Chapter 7 bankruptcy.

New Appointments:

Luca Scavo, Luca Scavo appointed as Chief Financial Officer and Chief Business Officer.

What Technology (Tech Stack) Is Used byEvelo Biosciences?

Discover the tools Evelo Biosciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Evelo Biosciences Email Formats and Examples

Historically, Evelo Biosciences likely used common corporate email formats. Given the company has ceased operations, these email addresses are no longer active.

[first_initial][last]@evelobio.com (e.g., jdoe@evelobio.com) or [first].[last]@evelobio.com (e.g. jane.doe@evelobio.com)

Format

sgill@evelobio.com

Example

0%

Success rate

What's the Latest News About Evelo Biosciences?

Endpoints NewsOctober 27, 2023

Evelo Biosciences news title: Flagship-backed Evelo Biosciences files for Chapter 7 bankruptcy

Evelo Biosciences, a company developing therapies based on microbial CBMs, filed for Chapter 7 bankruptcy. This move signals liquidation of assets and cessation of operations....more

BioSpaceOctober 30, 2023

Evelo Biosciences news title: Evelo Biosciences Files for Chapter 7 Bankruptcy, Will Liquidate Assets

Evelo Biosciences has filed for Chapter 7 bankruptcy, indicating it will cease operations and liquidate its assets. The company had been working on oral biologics for inflammatory diseases....more

PR NewswireJune 12, 2023

Evelo Biosciences news title: Evelo Biosciences Announces Appointment of Luca Scavo as Chief Financial Officer and Chief Business Officer

Evelo Biosciences announced the appointment of Luca Scavo as its new Chief Financial Officer (CFO) and Chief Business Officer (CBO), effective June 12, 2023. He succeeded Marella Thorell who stepped down....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Evelo Biosciences, are just a search away.